MA28191A1 -
NOVEL CRYSTALLINE FORM "ALPHA" OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
- Google Patents
NOVEL CRYSTALLINE FORM "ALPHA" OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
Info
Publication number
MA28191A1
MA28191A1MA28162AMA28162AMA28191A1MA 28191 A1MA28191 A1MA 28191A1MA 28162 AMA28162 AMA 28162AMA 28162 AMA28162 AMA 28162AMA 28191 A1MA28191 A1MA 28191A1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier LabfiledCriticalServier Lab
Priority to MA28162ApriorityCriticalpatent/MA28191A1/en
Publication of MA28191A1publicationCriticalpatent/MA28191A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
NOUVELLE FORME CRISTALLINE a DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT Forme cristalline a du composé de formule (I) : caractérisée par son diagramme de diffraction X sur poudre. Médicaments.NOVEL CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME OF THE FORMULA COMPOUND (I): characterized by its powder X-ray diffraction pattern. Drugs.
MA28162A2005-03-182005-03-18
NOVEL CRYSTALLINE FORM "ALPHA" OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28191A1
(en)
NOVEL CRYSTALLINE FORM "ALPHA" OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME